ExAblate uses MR guided focused ultrasound (MRgFUS) technology that combines MRI and high intensity focused ultrasound to thermally ablate tumors inside the body, non-invasively. The uniqueness of focused ultrasound guided by MR is its ability to monitor treatment outcome and control treatment parameters to achieve the planned outcome in real time. More than 9000 patients worldwide.
Two applications of ExAblate are commercially approved in the United States:
and there are ongoing clinical trials for other applications.
Key benefits of ExAblate treatment:
- Short recovery time, quick symptom relief
- Non-invasive, non-ionizing treatment with minimal discomfort and trauma
- One session, drug-sparing, no hospitalization
- No incisions, scars, post-operative complications or long-term sequelae
- Safe and effective